相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Nonneutralizing HIV-1 gp41 Envelope Cluster II Human Monoclonal Antibodies Show Polyreactivity for Binding to Phospholipids and Protein Autoantigens
S. Moses Dennison et al.
JOURNAL OF VIROLOGY (2011)
Two Closely Related Env Antigens from the Same Patient Elicited Different Spectra of Neutralizing Antibodies against Heterologous HIV-1 Isolates
Michael Vaine et al.
JOURNAL OF VIROLOGY (2011)
Heterologous Epitope-Scaffold Prime:Boosting Immuno-Focuses B Cell Responses to the HIV-1 gp41 2F5 Neutralization Determinant
Javier Guenaga et al.
PLOS ONE (2011)
Quantitative assessment of masking of neutralization epitopes in HIV-1
Alpna Agarwal et al.
VACCINE (2011)
Neutralizing Antibody Titers Conferring Protection to Macaques from a Simian/Human Immunodeficiency Virus Challenge Using the TZM-bl Assay
Ronald Willey et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2010)
Structural Conservation Predominates Over Sequence Variability in the Crown of HIV Type 1's V3 Loop
David Almond et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2010)
Soluble HIV-1 Env trimers in adjuvant elicit potent and diverse functional B cell responses in primates
Christopher Sundling et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Magnitude and Breadth of a Nonprotective Neutralizing Antibody Response in an Efficacy Trial of a Candidate HIV-1 gp120 Vaccine
Peter Gilbert et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Tiered Categorization of a Diverse Panel of HIV-1 Env Pseudoviruses for Assessment of Neutralizing Antibodies
Michael S. Seaman et al.
JOURNAL OF VIROLOGY (2010)
Breadth of Neutralizing Antibodies Elicited by Stable, Homogeneous Clade A and Clade C HIV-1 gp140 Envelope Trimers in Guinea Pigs
Joseph P. Nkolola et al.
JOURNAL OF VIROLOGY (2010)
Antibody-Mediated Protection against Mucosal Simian-Human Immunodeficiency Virus Challenge of Macaques Immunized with Alphavirus Replicon Particles and Boosted with Trimeric Envelope Glycoprotein in MF59 Adjuvant
Susan W. Barnett et al.
JOURNAL OF VIROLOGY (2010)
Conserved structural elements in the V3 crown of HIV-1 gp120
Xunqing Jiang et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)
Anti-V3 Monoclonal Antibodies Display Broad Neutralizing Activities against Multiple HIV-1 Subtypes
Catarina E. Hioe et al.
PLOS ONE (2010)
Comparative Immunogenicity of HIV-1 Clade C Envelope Proteins for Prime/Boost Studies
Douglas H. Smith et al.
PLOS ONE (2010)
Comparative Magnitude of Cross-Strain Conservation of HIV Variable Loop Neutralization Epitopes
James Swetnam et al.
PLOS ONE (2010)
Elicitation of structure-specific antibodies by epitope scaffolds
Gilad Ofek et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Vaccination with peptide mimetics of the gp41 prehairpin fusion intermediate yields neutralizing antisera against HIV-1 isolates
Elisabetta Bianchi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Computational Design of Epitope-Scaffolds Allows Induction of Antibodies Specific for a Poorly Immunogenic HIV Vaccine Epitope
Bruno E. Correia et al.
STRUCTURE (2010)
An optimally constrained V3 peptide is a better immunogen than its linear homolog or HIV-1 gp120
Adi Moseri et al.
VIROLOGY (2010)
Structure-guided design and immunological characterization of immunogens presenting the HIV-1 gp120 V3 loop on a CTB scaffold
Maxim Totrov et al.
VIROLOGY (2010)
Strategies for eliciting HIV-1 inhibitory antibodies
Georgia D. Tomaras et al.
CURRENT OPINION IN HIV AND AIDS (2010)
HIV vaccines: lessons learned and the way forward
Jerome H. Kim et al.
CURRENT OPINION IN HIV AND AIDS (2010)
Structure-function relationships of HIV-1 envelope sequence-variable regions refocus vaccine design
Susan Zolla-Pazner et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Worldwide Distribution of HIV Type 1 Epitopes Recognized by Human Anti-V3 Monoclonal Antibodies
Timothy Cardozo et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2009)
Human Immunodeficiency Virus Type 1 Env Trimer Immunization of Macaques and Impact of Priming with Viral Vector or Stabilized Core Protein
Andreas Moerner et al.
JOURNAL OF VIROLOGY (2009)
Factors Associated with the Development of Cross-Reactive Neutralizing Antibodies during Human Immunodeficiency Virus Type 1 Infection
D. Noah Sather et al.
JOURNAL OF VIROLOGY (2009)
Preferential use of the VH5-51 gene segment by the human immune response to code for antibodies against the V3 domain of HIV-1
Miroslaw K. Gorny et al.
MOLECULAR IMMUNOLOGY (2009)
Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals
Johannes F. Scheid et al.
NATURE (2009)
International Network for Comparison of HIV Neutralization Assays: The NeutNet Report
Eva Maria Fenyo et al.
PLOS ONE (2009)
Structural Basis of the Cross-Reactivity of Genetically Related Human Anti-HIV-1 mAbs: Implications for Design of V3-Based Immunogens
Valicia Burke et al.
STRUCTURE (2009)
Structural and immunogenicity studies of a cleaved, stabilized envelope trimer derived from subtype A HIV-1
Yun (Kenneth) Kang et al.
VACCINE (2009)
Cross-clade neutralizing antibodies against HIV-1 induced in rabbits by focusing the immune response on a neutralizing epitope
Susan Zolla-Pazner et al.
VIROLOGY (2009)
Simultaneous Evaluation of the Magnitude and Breadth of a Left- and Right-Censored Multivariate Response, With Application to HIV Vaccine Development
Yunda Huang et al.
STATISTICS IN BIOPHARMACEUTICAL RESEARCH (2009)
Structure determination of an anti-HIV-1 Fab 447-52D-peptide complex from an epitaxially twinned data set
Amandeep K. Dhillon et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2008)
Focused dampening of antibody response to the immunodominant variable loops by engineered soluble gp140
Suganya Selvarajah et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2008)
Profiling the Specificity of Neutralizing Antibodies in a Large Panel of Plasmas from Patients Chronically Infected with Human Immunodeficiency Virus Type 1 Subtypes B and C
James M. Binley et al.
JOURNAL OF VIROLOGY (2008)
Focusing the immune response on the V3 loop, a neutralizing epitope of the HIV-1 gp120 envelope
Susan Zolla-Pazner et al.
VIROLOGY (2008)
The impact of an AIDS vaccine in developing countries: A new model and initial results
John Stover et al.
HEALTH AFFAIRS (2007)
Extensively cross-reactive anti-HIV-1 neutralizing antibodies induced by gp140 immunization
Peng Fei Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Structure of a high-affinity Mimotope peptide bound to HIV-1-neutralizing antibody b12 explains its inability to elicit gp120 cross-reactive antibodies
Erica Ollmann Saphire et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Recombinant gp120 vaccine-induced antibodies inhibit clinical strains of HIV-1 in the presence of Fc receptor-bearing effector cells and correlate inversely with HIV infection rate
Donald N. Forthal et al.
JOURNAL OF IMMUNOLOGY (2007)
The role of antibody polyspecificity and lipid reactivity in binding of broadly neutralizing anti-HIV-1 envelope human monoclonal antibodies 2F5 and 4E10 to glycoprotein 41 membrane proximal envelope epitopes
S. Munir Alam et al.
JOURNAL OF IMMUNOLOGY (2007)
Antigenic and immunogenic study of membrane-proximal external region-grafted gp120 antigens by a DNA prime-protein boost immunization strategy
Mansun Law et al.
JOURNAL OF VIROLOGY (2007)
Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand
Punnee Pitisuttithum et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in southern Africa
Ming Li et al.
JOURNAL OF VIROLOGY (2006)
Cross-clade neutralizing activity of human anti-V3 monoclonal antibodies derived from the cells of individuals infected with non-B clades of human immunodeficiency virus type 1
Miroslaw K. Gorny et al.
JOURNAL OF VIROLOGY (2006)
Crystal structures of human immunodeficiency virus type 1 (HIV-1) neutralizing antibody 2219 in complex with three different V3 peptides reveal a new binding mode for HIV-1 cross-reactivity
Robyn L. Stanfield et al.
JOURNAL OF VIROLOGY (2006)
Anti-V3 humanized antibody KD-247 effectively suppresses ex vivo generation of human immunodeficiency virus type 1 and affords sterile protection of monkeys against a heterologous simian/human immunodeficiency virus infection
Yasuyuki Eda et al.
JOURNAL OF VIROLOGY (2006)
Comparing antigenicity and immunogenicity of engineered gp120
S Selvarajah et al.
JOURNAL OF VIROLOGY (2005)
Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies
M Li et al.
JOURNAL OF VIROLOGY (2005)
Evaluating the immunogenicity of a disulfide-stabilized, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1
S Beddows et al.
JOURNAL OF VIROLOGY (2005)
Correlation between immunologic responses to a recombinant glycoprotein 120 vaccine and incidence of HIV-1 infection in a phase 3 HIV-1 preventive vaccine trial
PB Gilbert et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
V3: HIV's switch-hitter
O Hartley et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2005)
The V3 loop is accessible on the surface of most human immunodeficiency virus type 1 primary isolates and serves as a neutralization epitope
MK Gorny et al.
JOURNAL OF VIROLOGY (2004)
Structural rationale for the broad neutralization of HIV-1 by human monoclonal antibody 447-52D
RL Stanfield et al.
STRUCTURE (2004)
Structure and mechanistic analysis of the anti-human immunodeficiency virus type 1 antibody 2F5 in complex with its gp41 epitope
G Ofek et al.
JOURNAL OF VIROLOGY (2004)
HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites
PD Kwong et al.
NATURE (2002)
Human monoclonal antibodies specific for conformation-sensitive epitopes of V3 neutralize human immunodeficiency virus type 1 primary isolates from various clades
MK Gorny et al.
JOURNAL OF VIROLOGY (2002)
Neutralization synergy of human immunodeficiency virus type 1 primary isolates by cocktails of broadly neutralizing antibodies
MB Zwick et al.
JOURNAL OF VIROLOGY (2001)
Additive effects characterize the interaction of antibodies involved in neutralization of the primary dualtropic human immunodeficiency virus type 1 isolate 89.6
F Verrier et al.
JOURNAL OF VIROLOGY (2001)
Antigenicity and immunogenicity of the HIV-1 gp41 epitope ELDKWA inserted into permissive sites of the MalE protein
E Coëffier et al.
VACCINE (2000)
Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies
JR Mascola et al.
NATURE MEDICINE (2000)
分享论文
